Deferred stenting (≥7 days) in patients with a high thrombus burden was safe on a background of GPI therapy.

An 84-year-old woman with a history of hemorrhagic stroke was admitted for a new cerebral ischemic event. While in hospital, she was diagnosed with paroxysmal atrial fibrillation. Owing to her high thromboembolic risk (CHA DS -VASc score of 6) we performed left atrial appendage (LAA) closure using a 22-mm AMPLATZER™ Amulet™. The procedure was successful. Systematic follow-up with transthoracic echocardiography 8 hr later revealed that the LAA occluder had migrated and become entrapped in the mitral subvalvular apparatus. At this time, the patient was asymptomatic. The device was recovered percutaneously using a loop-snare catheter, with no further complications. © 2016 Wiley Periodicals, Inc.

No abstract

Adrenaline infusion produced recovery of VA conduction in 10.9% of patients with absent VA conduction in a basal state. Recovery of VA conduction during physiological or pathological stresses could be responsible for the pacemaker syndrome, PMT episodes, or certain implantable cardiac defibrillator detection issues.

The finding of patent arteries on coronary angiography in patients hospitalized for ST-segment elevation myocardial infarction (STEMI) is not a rare phenomenon in daily practice. However, in a subgroup of these cases, namely patients with a history of drug-eluting stent implantation, intracoronary optical coherence tomography (OCT) may reveal angiographically silent stent thrombosis. We describe the case of a 64-year-old man admitted with clinical, electrocardiographic and biological features of STEMI, despite an angiographically patent stent and non-significant lesions in the coronary arteries. We emphasize the role of OCT in diagnosing the culprit artery, the etiopathologic substrate and therapeutic management in such cases.